Contractile response to exogenous prostaglandin E2 (PGE2) was studied in auricles from normal and acutely-diabetic (streptozotocin-treated) rats. In normal atria, PGE2 induced a biphasic inotropic effect negative at low concentrations and positive at higher ones. In diabetic, PGE2 only elicited a positive inotropic action which was greater in efficacy and potency than in normal controls. Incubation of diabetic atrial preparations with α-adrenoceptor antagonists (phentolamine, phenoxybenzamine or Prazosin) diminished the prostaglandin effect. However, blockade of β-adrenoceptors with propranolol did not modify the response. Blockers of arachidonic acid metabolism via cyclo-oxygenase (indomethacin and acetylsalicylic acid) or via lipoxygenase(s) (nordihydroguaiaretic acid and dithizone) were able to reduce the positive inotropism of PGE2. A significant blockade of the stimulant action of PGE2 was seen in the presence of inhibitors of thromboxane synthesis (L-8027 and imidazole). These results suggest that in diabetic atria PGE2 effect could be associated to an involvement of cardiac α-adrenergic stimulation which promotes endogenous arachidonic acid release with diversification of its metabolism towards cyclo- and lipoxygenase(s)- pathway and direct to an increased thromboxane formation which could account for the positive inotropic effect induced by PGE2. © 1986.
Documento: | Artículo |
Título: | Increase in atrial contractility induced by PGE2 in diabetic rats |
Autor: | Canga, L.; Sterin-Borda, L. |
Filiación: | Centro de Estudios Farmacologicos y de Principios Naturales (CEFAPRIN)-CONICET. Serrano 665/669, 1414 Buenos Aires, Argentina |
Palabras clave: | acetylsalicylic acid; alpha adrenergic receptor; dithizone; indometacin; nordihydroguaiaretic acid; phenoxybenzamine; phentolamine; prazosin; propranolol; prostaglandin e2; streptozocin; animal cell; animal experiment; arachidonic acid metabolism; drug efficacy; endocrine system; heart; heart atrium; heart muscle; heart muscle contractility; intravenous drug administration; nonhuman; priority journal; rat; streptozocin diabetes; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animal; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Dinoprostone; In Vitro; Lipoxygenase Inhibitors; Male; Myocardial Contraction; Prostaglandins E; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't; Thromboxane-A Synthase |
Año: | 1986 |
Volumen: | 18 |
Número: | 4 |
Página de inicio: | 371 |
Página de fin: | 384 |
DOI: | http://dx.doi.org/10.1016/0031-6989(86)90090-1 |
Título revista: | Pharmacological Research Communications |
Título revista abreviado: | Pharmacol. Res. Commun. |
ISSN: | 00316989 |
CODEN: | PLRCA |
CAS: | acetylsalicylic acid, 493-53-8, 50-78-2, 53663-74-4, 53664-49-6, 63781-77-1; dithizone, 60-10-6; indometacin, 53-86-1, 74252-25-8, 7681-54-1; nordihydroguaiaretic acid, 500-38-9; phenoxybenzamine, 59-96-1, 63-92-3; phentolamine, 50-60-2, 73-05-2; prazosin, 19216-56-9, 19237-84-4; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; prostaglandin E2, 363-24-6; streptozocin, 18883-66-4; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Arachidonic Acid, 506-32-1; Arachidonic Acids; Cyclooxygenase Inhibitors; Dinoprostone, 363-24-6; Lipoxygenase Inhibitors; Prostaglandins E; Thromboxane-A Synthase, EC 5.3.99.5 |
Registro: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00316989_v18_n4_p371_Canga |